Mesoblast Limited Stock Analysis & AI Score
Mesoblast Limited (MESO) has an ST Score of 64.1 (B), driven by its Profitability (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $39.00 price target (+151.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Mesoblast Limited (MESO) has an ST Score of 64.1 (B), driven by its Profitability (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $39.00 price target (+151.9% upside).
- Strongest
- ProfitabilityA
- Weakest
- Financial StrengthD-
All factor grades
- ProfitabilityA
- GrowthA
- ForecastA
- MomentumA-
- ValuationB-
- Financial StrengthD-
- Piotroski4/9
Contact
MESO stock: frequently asked questions
What is MESO's ST Score?
Mesoblast Limited (MESO) has an ST Score of 64.1 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MESO a buy, hold, or sell?
Analysts rate MESO a Buy, with a price target of $39.00 (+151.9% vs the current price). Our ST Score grades it B (64.1/100). The ST Score is a data-driven signal, not a recommendation.
What are MESO's factor grades?
Valuation B-, Profitability A, Financial Strength D-, Momentum A-, Growth A, Forecast A.
What is MESO's valuation grade?
Mesoblast Limited (MESO) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MESO's growth grade?
Mesoblast Limited (MESO) earns a growth grade of A, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MESO's profitability grade?
Mesoblast Limited (MESO) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MESO's financial strength grade?
Mesoblast Limited (MESO) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MESO?
The average analyst price target for Mesoblast Limited (MESO) is $39.00 from 11 analysts, which is +151.9% versus the recent price of $15.48.
What is MESO's Piotroski score?
Mesoblast Limited (MESO) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.